http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A study of patients treated with the anticoagulant medication warfarin suggests that resuming warfarin therapy after an episode of gastrointestinal tract bleeding was associated with lower risk for thrombosis (blood clot) and death, according to a report published Online First by Archives of Internal Medicine. http://medicalxpress.com/news/2012-09-resuming-warfarin-gastrointestinal-tract-linked.html Diseases, Conditions, Syndromes Mon, 17 Sep 2012 16:00:04 EST news267098603 In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women, according to a study in the May 9 issue of JAMA. http://medicalxpress.com/news/2012-05-greater-women-men-older-patients.html Cardiology Tue, 08 May 2012 16:00:01 EST news255710515 The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with heart attack undergoing primary angioplasty with bivalirudin anticoagulation. The HORIZONS-AMI II trial will also investigate the chronic use of the antiplatelet medications prasugrel versus clopidogrel in patients free of major events at 30 days. http://medicalxpress.com/news/2012-03-cardiovascular-foundation-horizons-ami-ii-clinical.html Cardiology Tue, 27 Mar 2012 09:58:18 EST news252060971 Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer. http://medicalxpress.com/news/2011-07-cancer-patients-blood-clots-gain.html Cancer Thu, 07 Jul 2011 06:54:23 EST news229240221 Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent (paclitaxel) was also shown to be more effective than a bare-metal stent, with equivalent safety. Final 3-year results of the trial were published in the June 13, 2011, issue of The Lancet. http://medicalxpress.com/news/2011-06-year-results-landmark-horizons-ami-trial.html Cardiology Mon, 13 Jun 2011 10:17:00 EST news227178972